Regeneron Pharmaceuticals, Inc.
RODENTS HAVING GENETICALLY MODIFIED SODIUM CHANNELS AND METHODS OF USE THEREOF
Last updated:
Abstract:
Disclosed herein are rodents (such as mice and rats) genetically modified at an endogenous Scn9a locus to comprise an exogenous Scn nucleotide sequence such as the coding sequence of a human SCN2A gene. Also disclosed are methods and compositions useful for making such rodents, and methods of using such rodents for generating anti-NaV1.7 antibodies.
Status:
Application
Type:
Utility
Filling date:
21 Feb 2020
Issue date:
27 Aug 2020